HyperSinc
WIRELIVE
DeepFUNDING · · 1 OUTLET

Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells - EU-Startups

via EU-Startups

KEY TAKEAWAYS
  • Jülich-based SRTD Biotech raised €32M.
  • Single source so far: Google News · funding.
TIMELINE
Google News · funding breaks the story
READ AT SOURCE →
J/K NEXT STORY · ESC BACK TO TAPE42 SOURCES